Christopher Heery is CHIEF MEDICAL OFFICER at Arcellx, Inc. (ACLX). They have made 22 open-market trades across 2 companies since 2019, most recently 2026-01-14.
CIK 0001789632
1 open-market purchase totalling $30K since 2019, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACLX | 23,749 | $2.7M |
| DTIL | 250 | $1K |
| Total | $2.7M |
Shares reported on the most recent Form 4, priced at the 2026-01-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACLX | SELL | 2026-01-14 | 2026-01-14 | $68.51 | $403K | -1.8% | -1.9% | +64.6% |
| ACLX | SELL | 2026-01-13 | 2026-01-13 | $65.51 | $487K | +3.0% | +3.2% | +72.6% |
| ACLX | SELL | 2026-01-12 | 2026-01-12 | $64.15 | $393K | +5.1% | +8.5% | +78.4% |
| ACLX | SELL · 10b5-1 | 2025-11-17 | 2025-11-17 | $90.00 | $31K | -18.6% | -27.5% | -21.4% |
| ACLX | SELL · 10b5-1 | 2025-09-30 | 2025-09-30 | $81.36 | $2.9M | +7.5% | +8.4% | -19.3% |
| ACLX | SELL · 10b5-1 | 2025-09-29 | 2025-09-29 | $80.16 | $6K | +11.6% | +8.7% | -17.7% |
| ACLX | SELL · 10b5-1 | 2025-09-26 | 2025-09-26 | $80.12 | $2.0M | +11.9% | +9.9% | -16.7% |
| ACLX | SELL · 10b5-1 | 2025-09-18 | 2025-09-19 | $80.01 | $559K | +5.4% | +11.5% | -17.6% |
| ACLX | SELL | 2025-02-24 | 2025-02-24 | $63.78 | $1.3M | +8.6% | +11.0% | -1.9% |
| ACLX | SELL | 2025-01-07 | 2025-01-10 | $74.69 | $1.2M | -4.6% | -2.2% | -17.3% |
| ACLX | SELL | 2025-01-03 | 2025-01-10 | $78.36 | $932K | -4.6% | -2.2% | -17.3% |
| ACLX | SELL | 2025-01-03 | 2025-01-06 | $78.40 | $499K | -11.5% | -8.7% | -24.6% |
| ACLX | SELL · 10b5-1 | 2024-09-05 | 2024-09-06 | $70.02 | $479K | +12.7% | +6.4% | +20.9% |
| ACLX | SELL · 10b5-1 | 2024-09-03 | 2024-09-03 | $66.99 | $3.6M | +17.4% | +16.3% | +46.1% |
| ACLX | SELL · 10b5-1 | 2024-08-26 | 2024-08-28 | $71.12 | $3.1M | +5.9% | +18.1% | +29.8% |
| ACLX | SELL · 10b5-1 | 2024-08-16 | 2024-08-19 | $65.05 | $709K | +2.4% | +22.3% | +33.9% |
| ACLX | SELL · 10b5-1 | 2024-08-01 | 2024-08-02 | $60.40 | $2.4M | +23.0% | +34.9% | +72.0% |
| ACLX | SELL · 10b5-1 | 2024-07-16 | 2024-07-18 | $65.30 | $1.4M | -1.2% | +6.3% | +49.0% |
| ACLX | SELL · 10b5-1 | 2024-07-11 | 2024-07-12 | $60.08 | $655K | -1.6% | -6.6% | +31.4% |
| ACLX | SELL · 10b5-1 | 2024-07-01 | 2024-07-03 | $55.39 | $2.2M | +21.0% | +1.6% | +49.5% |
| ACLX | SELL · 10b5-1 | 2024-06-12 | 2024-06-14 | $55.13 | $2.2M | -0.5% | +16.5% | +37.5% |
| ACLX | SELL · 10b5-1 | 2024-05-01 | 2024-05-03 | $51.31 | $1.8M | -1.6% | +2.1% | +11.6% |
| ACLX | SELL · 10b5-1 | 2024-03-22 | 2024-03-26 | $70.03 | $6.5M | -14.0% | -27.2% | -20.6% |
| ACLX | SELL | 2024-02-08 | 2024-02-12 | $63.33 | $1.3M | -0.1% | +13.6% | -19.8% |
| ACLX | SELL | 2024-01-04 | 2024-01-08 | $55.27 | $840K | +4.9% | +21.2% | +15.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.